THC
58
-4
PSX
39
5
L
60
2
PPL
67
-2
QRVO
36
-4
PRGO
48
-2
AIG
53
2
C
54
4
CMCSA
46
-2
NDAQ
59
-3
TGNA
48
5
ROST
60
-2
IRM
71
-4
GM
57
2
AVGO
40
-24
MDT
53
-4
AMG
41
3
EXPD
54
7
AZO
45
-3
COP
50
3
THC
58
-4
PSX
39
5
L
60
2
PPL
67
-2
QRVO
36
-4
PRGO
48
-2
AIG
53
2
C
54
4
CMCSA
46
-2
NDAQ
59
-3
TGNA
48
5
ROST
60
-2
IRM
71
-4
GM
57
2
AVGO
40
-24
MDT
53
-4
AMG
41
3
EXPD
54
7
AZO
45
-3
COP
50
3
Financhill
Back

icad Vs. Perspective Therapeutics Industry Stock Comparison

Sell
45

ICAD
icad

Last Price:
1.64
Seasonality Move:
5.57%
Sell
30

CATX
Perspective Therapeutics

Last Price:
13.38
Seasonality Move:
-10.19%
Sell
45
icad (ICAD) is a Sell

Is icad a Buy, Sell or Hold?

  • The current icad [ICAD] share price is $1.65. The Score for ICAD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • ICAD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $13.32. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ICAD Stock Price Chart

What is icad's stock price today?

  • The icad share price today is $1.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ICAD is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $13.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ICAD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 61.15 Buy
Chaikin Money Flow: -16057 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.45 - 1.67) Buy
Bollinger Bands (100): (1.3 - 1.6) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 41.66 Sell
Chaikin Money Flow: 400659 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.87 - 15.77) Sell
Bollinger Bands (100): (11.56 - 16.02) Sell

ICAD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.5 Buy
20-day SMA: 1.56 Buy
50-day SMA: 1.43 Buy
200-day SMA: 1.53 Buy
8-day EMA: 1.56 Buy
20-day EMA: 1.52 Buy
50-day EMA: 1.48 Buy
200-day EMA: 1.56 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.97 Sell
20-day SMA: 15.14 Sell
50-day SMA: 13.64 Sell
200-day SMA: 11.16 Buy
8-day EMA: 14.56 Sell
20-day EMA: 14.66 Sell
50-day EMA: 14 Sell
200-day EMA: 11.47 Buy

icad Earnings Growth & ICAD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.03 per share, an increase this year of $0.04 per share, and an increase next year of $0.05 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.

icad Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):